| Not Yet Recruiting | Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Hnscc, Head and Neck, Squamous Cell Cancer | Phase 1 | 2026-04-30 |
| Not Yet Recruiting | Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disea SCC - Squamous Cell Carcinoma, Radiotracer, Head and Neck Squamous Cell Carcinoma | Phase 1 | 2026-04-01 |
| Not Yet Recruiting | Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy Locally Advanced Cancer, Metastatic Cancer, HER2 | EARLY_Phase 1 | 2026-02-01 |
| Recruiting | High-Resolution PET-CT Imaging for Surgical Margin Visualization Cancer, Solid Malignant Tumors, SCC - Squamous Cell Carcinoma | N/A | 2025-09-03 |
| Recruiting | Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer HNSCC, HNSCC,Larynx, Pharynx and Oral Cavity, SCC - Squamous Cell Carcinoma | EARLY_Phase 1 | 2025-04-17 |
| Active Not Recruiting | Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules Lung Neoplasm | N/A | 2024-10-31 |
| Recruiting | Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial Stage I Lung Cancer, Stage II Lung Cancer | N/A | 2024-09-27 |
| Recruiting | EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing Lung Cancer | Phase 4 | 2024-09-13 |
| Recruiting | Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia Relapsed Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 | 2024-08-14 |
| Recruiting | Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreati Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine Neoplasm | Phase 4 | 2024-05-31 |
| Recruiting | Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer | Phase 2 | 2024-05-30 |
| Recruiting | Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer | Phase 1 / Phase 2 | 2024-04-24 |
| Recruiting | A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules Pulmonary Nodule | — | 2024-03-07 |
| Terminated | Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer | Phase 2 | 2024-02-14 |
| Recruiting | Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | 2023-10-03 |
| Recruiting | Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | 2023-08-22 |
| Recruiting | Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy Metastatic HER2-Negative Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma | Phase 2 | 2023-08-04 |
| Recruiting | Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy Head and Neck Squamous Cell Carcinoma, Brain Metastases | EARLY_Phase 1 | 2023-05-17 |
| Suspended | Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 In Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma | Phase 2 | 2023-05-09 |
| Recruiting | Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lun Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage III Lung Cancer | Phase 1 / Phase 2 | 2023-05-09 |
| Recruiting | Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 | Phase 2 | 2022-12-01 |
| Active Not Recruiting | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor Gastric Cancer, Metaplasia, Stage I Gastric Cancer | Phase 1 | 2022-11-09 |
| Active Not Recruiting | Improving Care After Inherited Cancer Testing Inherited Cancer Syndrome, Prostate Cancer, Colorectal Cancer | N/A | 2022-08-05 |
| Recruiting | Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan Sarcoma | — | 2022-04-01 |
| Completed | Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma | Phase 4 | 2021-12-02 |
| Completed | Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents Advanced Cancer, Relapsed Cancer, Refractory Cancer | N/A | 2021-03-31 |
| Recruiting | Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas Soft Tissue Sarcomas | Phase 2 | 2021-03-02 |
| Completed | Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer Renal Cell Carcinoma | — | 2021-01-06 |
| Completed | Metabolism Informed Smoking Treatment: The MIST RCT Smoking | Phase 3 | 2020-11-17 |
| Recruiting | The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository Clonal Hematopoiesis | — | 2020-10-28 |
| Terminated | Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System Thyroid Carcinoma, Radioactive Iodine Level | Phase 2 | 2020-10-05 |
| Terminated | Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal Fallopian Tube Cancer, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma | Phase 1 | 2020-10-01 |
| Completed | Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration Lung Nodule | N/A | 2020-05-22 |
| Active Not Recruiting | COVID-19 and Cancer Consortium Registry COVID-19, Invasive Malignancy (Any Type) | — | 2020-03-17 |
| Completed | Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy. Postoperative Hypoparathyroidism, Thyroid Neoplasms, Thyroid Cancer | N/A | 2020-03-16 |
| Completed | Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy Parathyroid Adenoma, Parathyroid Neoplasms, Parathyroid Hyperplasia | N/A | 2020-03-13 |
| Terminated | Central Pain Syndrome in Survivors of Head and Neck Cancer Head and Neck Cancer | N/A | 2019-11-04 |
| Terminated | Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Neuroendocrine Tumor, Carcinoid Syndrome | N/A | 2019-11-04 |
| Terminated | Yoga Intervention in Head and Neck Cancer Patients Undergoing Concurrent Chemo-Radiation Head and Neck Cancer | N/A | 2019-10-28 |
| Withdrawn | ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Le Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2019-08-27 |
| Terminated | Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion Malignant Neoplasm | N/A | 2019-08-07 |
| Completed | A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer Estrogen Receptor-positive Breast Cancer | EARLY_Phase 1 | 2019-07-08 |
| Unknown | Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant Diabetes Mellitus, Cancer | — | 2019-03-12 |
| Completed | Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents Advanced Cancer, Relapsed Cancer, Refractory Cancer | N/A | 2019-02-21 |
| Recruiting | Studying Health Outcomes After Treatment in Patients With Retinoblastoma Retinoblastoma, Cancer Survivor, Biological Sibling | — | 2019-01-24 |
| Active Not Recruiting | Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence Malignant Solid Tumor | Phase 2 | 2018-12-12 |
| Withdrawn | Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck Recurrent Squamous Cell Carcinoma of the Head or Neck, Metastatic Squamous Cell Carcinoma of the Head or Neck, Squamous Cell Carcinoma | Phase 1 | 2018-11-02 |
| Terminated | Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Extensive Stage Small Cell Lung Carcinoma | N/A | 2018-09-05 |
| Terminated | Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen R Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer | Phase 1 / Phase 2 | 2018-07-10 |
| Completed | Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors Thymic Carcinoma, Non-small Cell Lung Cancer, Refractory Thoracic Tumors | Phase 1 / Phase 2 | 2018-07-10 |
| Terminated | Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Cente Recurrent Central Nervous System Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Refractory Central Nervous System Lymphoma | Phase 1 | 2018-06-14 |
| Withdrawn | PET Imaging of Ovarian Carcinoma With 18F-FSPG Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer | EARLY_Phase 1 | 2018-06-01 |
| Terminated | Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors Non-Small Cell Lung Carcinoma, Small Cell Lung Carcinoma | N/A | 2018-04-05 |
| Withdrawn | Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer | Phase 2 | 2017-12-29 |
| Active Not Recruiting | Early Detection of Lung Cancer Lung Cancer | — | 2017-12-14 |
| Withdrawn | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma | Phase 1 | 2017-12-01 |
| Completed | High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients Hematopoietic Cell Transplantation | Phase 2 | 2017-10-09 |
| Completed | Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy Melanoma | — | 2017-10-03 |
| Completed | Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer Triple Negative Breast Cancer, Stage IV Breast Cancer, HER2 Negative | Phase 2 | 2017-08-29 |
| Completed | Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Meta Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer | Phase 1 / Phase 2 | 2017-08-23 |
| Completed | Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer Metastatic Breast Cancer | Phase 1 | 2017-08-18 |
| Completed | Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase I Myelodysplastic Syndromes, Myeloproliferative Neoplasm | Phase 2 | 2017-08-07 |
| Terminated | Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Ca Non-Small Cell Lung Carcinoma | Phase 1 | 2017-07-20 |
| Terminated | Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma Adenocarcinoma | Phase 2 | 2017-03-03 |
| Recruiting | Inherited CAncer REgistry Cancer | — | 2017-02-27 |
| Completed | Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant Blastoid Variant Mantle Cell Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Follicular Lymphoma | Phase 2 | 2016-11-01 |
| Completed | Chemoprevention of Gastric Carcinogenesis Gastric Cancer, Gastric Intestinal Metaplasia | Phase 2 | 2016-09-19 |
| Terminated | Hatha Yoga in Breast Cancer Survivors Breast Carcinoma, Lymphedema | N/A | 2016-09-01 |
| Completed | Visually Enhanced Education About Prostate Cancer Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer | N/A | 2016-09-01 |
| Completed | Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors With Lymphedema and Fibrosis Lymphedema | — | 2016-09-01 |
| Completed | High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant Hematopoietic Cell Transplantation Recipient, Malignant Neoplasm, Influenza | Phase 2 | 2016-09-01 |
| Recruiting | Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fu Recurrent Mycosis Fungoides, Refractory Mycosis Fungoides, Stage I Mycosis Fungoides | — | 2016-05-22 |
| Completed | Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negat Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative | Phase 1 | 2016-03-01 |
| Completed | Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Multilineage Dysplasia | Phase 2 | 2016-03-01 |
| Completed | Impact of Pleural Manometry on Chest Discomfort After Therapeutic Thoracentesis Pleural Effusion | N/A | 2016-01-01 |
| Completed | PCRC-Supported Legacy Intervention in Pediatric Palliative Care Care Giver, Recurrent Malignant Neoplasm, Refractory Malignant Neoplasm | N/A | 2015-07-27 |
| Completed | TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea Myelofibrosis, Polycythemia Vera | Phase 1 | 2015-07-01 |
| Completed | Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study Localized Non-Resectable Adult Liver Carcinoma | — | 2015-07-01 |
| Completed | Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Ca Malignant Head and Neck Neoplasm, Mucositis, Radiation-Induced Disorder | Phase 3 | 2015-07-01 |
| Completed | 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior | Phase 2 | 2015-06-16 |
| Terminated | Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Bre Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative | Phase 1 / Phase 2 | 2015-06-01 |
| Completed | Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients Oral Cavity Cancer, Oropharyngeal Cancer, Lymphedema | N/A | 2015-06-01 |
| Terminated | Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers Cancer | N/A | 2015-05-01 |
| Terminated | Pembrolizumab in Treating Patients With Advanced Uveal Melanoma Stage IIIA Uveal Melanoma, Stage IIIB Uveal Melanoma, Stage IIIC Uveal Melanoma | Phase 2 | 2015-05-01 |
| Terminated | Quantitative MRI in Assessing Disease in Patients With Brain Tumors Tumors Metastatic to Brain, Unspecified Adult Solid Tumor, Protocol Specific | N/A | 2015-04-01 |
| Terminated | 18F-FES PET/CT in Imaging Patients With Desmoid Tumors Deep Fibromatosis/Desmoid Tumor, Familial Adenomatous Polyposis | EARLY_Phase 1 | 2015-04-01 |
| Completed | Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma | Phase 2 | 2015-01-01 |
| Completed | Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiatio Head and Neck Cancer, Pain, Lung Cancer | N/A | 2014-12-01 |
| Terminated | Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant Diabetes Mellitus, Malignant Neoplasm | N/A | 2014-11-20 |
| Terminated | Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE) Graft Versus Host Disease | — | 2014-08-29 |
| Completed | Programs to Support You During Chemotherapy (Pro-You) Depressive Symptoms, Fatigue, Psychosocial Effects of Cancer and Its Treatment | N/A | 2014-08-01 |
| Terminated | Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer Survivors Head and Neck Cancer, Lymphedema | N/A | 2014-06-01 |
| Withdrawn | Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient W Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 2 | 2014-06-01 |
| Terminated | 3-Tesla MRI Response to TACE in HCC (Liver Cancer) Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Resectable Adult Primary Liver Cancer | N/A | 2014-02-01 |
| Terminated | GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2013-09-01 |
| Completed | Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors Head Neck Cancer | N/A | 2013-08-01 |
| Completed | A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Malignant Glioma | Phase 1 | 2013-07-01 |
| Completed | ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients Childhood Acute Lymphoblastic Leukemia in Remission | N/A | 2013-05-01 |
| Unknown | Non-Myeloablative Conditioning and Bone Marrow Transplantation Sickle Cell Disease, Hemoglobinopathies | N/A | 2013-05-01 |
| Active Not Recruiting | BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma | Phase 1 | 2013-04-01 |
| Terminated | Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma Osteosarcoma, Paget's Disease, Ewing Sarcoma | N/A | 2013-03-01 |
| Terminated | Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Region Recurrent Melanoma, Stage IIB Melanoma (Locally Advanced), Stage IIC Melanoma (Locally Advanced) | Phase 2 | 2013-01-01 |
| Terminated | Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer Breast Cancer | N/A | 2013-01-01 |
| Terminated | Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer Adenocarcinoma of the Lung, Recurrent Non-small Cell Lung Cancer, Stage IA Non-small Cell Lung Cancer | EARLY_Phase 1 | 2012-10-01 |
| Terminated | FDG-PET in Advanced Melanoma Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma | N/A | 2012-05-01 |
| Terminated | 3T MRI Biomarkers of Glioma Treatment Response Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma | EARLY_Phase 1 | 2012-05-01 |
| Terminated | Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma Recurrent Melanoma, Stage IIIc Melanoma, Stage IV Melanoma | Phase 2 | 2011-10-01 |
| Terminated | Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photoph Graft Versus Host Disease (GVHD) | N/A | 2011-07-01 |
| Terminated | Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer | Phase 2 | 2011-06-01 |
| Active Not Recruiting | Nashville Early Diagnosis Lung Cancer Project Lung Cancer | — | 2011-04-01 |
| Completed | Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases Tumors Metastatic to Brain | Phase 1 | 2011-02-01 |
| Withdrawn | Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer Metastatic Breast Cancer | Phase 2 | 2011-02-01 |
| Terminated | PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer | Phase 2 | 2010-12-01 |
| Completed | First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Ini Multiple Myeloma | Phase 2 | 2010-11-01 |
| Completed | PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breas Metastatic Breast Cancer | Phase 1 | 2010-11-01 |
| Completed | Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Reci Adult Stem Cell Hematopoetic Transplant | Phase 1 | 2010-10-01 |
| Terminated | PET/CT Evaluation of Treatment Response in Breast Cancer Breast Cancer | N/A | 2010-10-01 |
| Recruiting | Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Melanoma | — | 2010-06-03 |
| Terminated | Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer Hormone-sensitive Metastatic Breast Cancer | Phase 2 | 2010-05-01 |
| Terminated | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor Breast Cancer, Cardiovascular Complications, Colorectal Cancer | — | 2010-03-01 |
| Completed | 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer Neuroendocrine Carcinoma | Phase 2 | 2010-03-01 |
| Completed | Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer Rectal Cancer | Phase 1 | 2010-03-01 |
| Terminated | Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel Arthralgia, Pain, Unspecified Adult Solid Tumor, Protocol Specific | — | 2009-11-01 |
| Completed | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer | Phase 1 | 2009-11-01 |
| Completed | Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2009-10-01 |
| Completed | Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer Pancreatic Cancer, Periampullary Adenocarcinoma | Phase 1 | 2009-10-01 |
| Terminated | Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surger Breast Cancer | N/A | 2009-09-01 |
| Completed | Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer Lung Cancer | Phase 2 | 2009-09-01 |
| Withdrawn | Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer Breast Cancer | Phase 2 | 2009-08-01 |
| Terminated | Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Lung Cancer | — | 2009-07-01 |
| Completed | Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Can Breast Cancer | Phase 2 | 2009-06-01 |
| Terminated | Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lu Lung Cancer, Metastatic Cancer | Phase 1 | 2009-05-01 |
| Terminated | Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Canc Cancer | — | 2009-01-01 |
| Terminated | Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant Cancer | — | 2008-11-01 |
| Completed | Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-C Lymphoma | Phase 2 | 2008-10-01 |
| Completed | Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia | Phase 3 | 2008-10-01 |
| Completed | Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery Pancreatic Cancer | Phase 2 | 2008-10-01 |
| Withdrawn | Opioids Titration in Hospice Patients Pain, Solid Tumor | — | 2008-06-01 |
| Completed | PET Study in Patients With Non-Hodgkin Lymphoma Lymphoma | — | 2008-05-01 |
| Completed | Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer Breast Cancer | Phase 1 | 2008-05-01 |
| Completed | Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants Healthy, no Evidence of Disease, Lung Cancer | — | 2008-04-01 |
| Terminated | Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surger Breast Cancer | EARLY_Phase 1 | 2008-03-01 |
| Terminated | Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC Lung Cancer | Phase 1 / Phase 2 | 2007-11-01 |
| Completed | Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurr Lung Cancer | Phase 2 | 2007-10-01 |
| Terminated | Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2007-10-01 |
| Withdrawn | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer Myeloproliferative Disorders, Leukemia, Lymphoma | N/A | 2007-08-01 |
| Completed | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophag Gastric Cancer | Phase 2 | 2007-08-01 |
| Completed | Family Quality of Life Among Families With a Member Who is a Cancer Patient Breast Cancer, Colorectal Cancer, Head and Neck Cancer | — | 2007-08-01 |
| Terminated | Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose M Mucositis, Multiple Myeloma and Plasma Cell Neoplasm | — | 2007-07-01 |
| Terminated | PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE Breast Cancer | Phase 2 | 2007-07-01 |
| Terminated | Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors Gastrointestinal Stromal Tumor | Phase 1 | 2007-07-01 |
| Withdrawn | Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer Liver Cancer | — | 2007-07-01 |
| Completed | Pain Control in Hospice Patients With Cancer-Related Pain Pain, Solid Tumor | — | 2007-07-01 |
| Completed | Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squa Head and Neck Cancer | — | 2007-06-01 |
| Completed | Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer Head and Neck Cancer | — | 2007-05-01 |
| Completed | Studying Biomarkers in Patients With Pancreatic Cancer Pancreatic Cancer | — | 2007-05-01 |
| Terminated | Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Met Head and Neck Cancer | — | 2007-04-01 |
| Withdrawn | A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia Leukemia | Phase 2 | 2007-03-01 |
| Completed | Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer Breast Cancer | — | 2007-02-01 |
| Completed | Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer Breast Cancer, Depression, Fatigue | N/A | 2007-02-01 |
| Completed | Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer Pancreatic Cancer | — | 2007-01-01 |
| Completed | Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor | — | 2007-01-01 |
| Terminated | T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor | — | 2006-12-01 |
| Completed | Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2006-12-01 |
| Completed | Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer Ovarian Cancer | — | 2006-11-01 |
| Completed | Immunoreactivity to Cetuximab in Cancer Patients Colorectal Cancer, Head and Neck Cancer | — | 2006-11-01 |
| Terminated | Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Cro Melanoma | — | 2006-10-01 |
| Completed | DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer Head and Neck Cancer | — | 2006-06-01 |
| Completed | Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx Head and Neck Cancer | — | 2006-05-01 |
| Terminated | Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer Solid Tumor | — | 2006-05-01 |
| Completed | Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants Breast Cancer | N/A | 2006-03-01 |
| Terminated | Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Neurotoxicity | Phase 1 | 2006-02-01 |
| Completed | Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients Solid Tumor | — | 2006-02-01 |
| Completed | Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Pro Cancer Pain | — | 2006-01-01 |
| Completed | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer Breast Cancer, Colorectal Cancer, Head and Neck Cancer | — | 2006-01-01 |
| Terminated | Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia Dysphagia, Head and Neck Cancer, Mucositis | Phase 2 | 2006-01-01 |
| Completed | Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer Breast Cancer | Phase 1 | 2005-12-01 |
| Completed | Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer Lung Cancer | — | 2005-12-01 |
| Completed | PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca Pancreatic Cancer | Phase 1 | 2005-10-01 |
| Terminated | Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimu Graft Versus Host Disease, Leukemia, Lymphoma | N/A | 2005-09-01 |
| Completed | Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2005-08-01 |
| Completed | Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery Colorectal Cancer | Phase 2 | 2005-05-01 |
| Completed | Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | 2005-05-01 |
| Completed | Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer Head and Neck Cancer | — | 2005-02-01 |
| Completed | Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 Lymphoma, Solid Tumor | — | 2005-01-01 |
| Completed | Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma Melanoma | Phase 2 | 2004-09-01 |
| Completed | A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC Head and Neck Cancer | — | 2004-05-01 |
| Completed | Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma Lymphoma, Solid Tumor | Phase 1 | 2004-05-01 |
| Terminated | Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Lung Cancer | Phase 2 | 2004-02-01 |
| Terminated | Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer Breast Cancer | Phase 2 | 2004-02-01 |
| Recruiting | Collecting and Storing Tissue Samples From Women With or Without Breast Cancer Breast Cancer | — | 2004-01-22 |
| Terminated | ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Prostate Cancer | Phase 1 / Phase 2 | 2004-01-01 |
| Unknown | Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer Lung Cancer | — | 2003-12-01 |
| Completed | Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Can Lung Cancer | Phase 2 | 2003-12-01 |
| Terminated | Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery Liver Cancer | N/A | 2003-12-01 |
| Terminated | Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors Head and Neck Cancer, Islet Cell Tumor, Metastatic Cancer | Phase 2 | 2003-12-01 |
| Terminated | Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. Breast Cancer | Phase 2 | 2003-11-01 |
| Completed | Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer Anxiety Disorder, Head and Neck Cancer, Lung Cancer | — | 2003-11-01 |
| Terminated | Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Head and Neck Cancer | — | 2003-11-01 |
| Completed | Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics Breast Cancer | N/A | 2003-11-01 |
| Terminated | Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma Brain and Central Nervous System Tumors, Melanoma, Solid Tumor | Phase 1 / Phase 2 | 2003-06-01 |
| Terminated | Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | 2003-05-01 |
| Terminated | Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE) Lung Cancer | — | 2003-04-01 |
| Terminated | Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast Breast Cancer | Phase 2 | 2002-10-01 |
| Completed | Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery Breast Cancer | Phase 2 | 2002-08-01 |
| Completed | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer T Colorectal Cancer | Phase 2 | 2002-07-01 |
| Terminated | Celecoxib in Treating Patients With Early-Stage Rectal Cancer Colorectal Cancer | N/A | 2002-07-01 |
| Completed | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2002-07-01 |
| Completed | National Registry and Blood Bank of Patients With Liver Cancer Liver Cancer | — | 2002-04-01 |
| Completed | Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2002-02-01 |
| Recruiting | Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer Lung Cancer | — | 2001-05-01 |
| Completed | Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer Lung Cancer | N/A | 2000-12-01 |
| Completed | Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Canc Breast Cancer | N/A | 2000-02-01 |
| Completed | Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer Breast Cancer | Phase 2 | 1998-09-01 |
| Completed | Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer Lung Cancer | Phase 1 | 1997-01-01 |
| Withdrawn | MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer Metastatic Breast Cancer | Phase 1 | — |